Why Is Imuran So Hard to Find? [Explained for 2026]

If you've been trying to fill a prescription for Imuran (azathioprine) lately and run into empty shelves or confusing answers from pharmacists, you're not alone. While the oral tablet supply is not in a formal FDA shortage, patients across the country continue to report difficulty finding this medication — particularly at smaller or rural pharmacies. Here is a plain-English breakdown of what is going on and what you can do about it.

Is Imuran Actually in Shortage in 2026?

The answer depends on the formulation. The injectable form of azathioprine — azathioprine sodium 100 mg vials — is officially on the FDA drug shortage list. Hikma, one of the primary manufacturers of the injectable, placed its vials on back order in late 2024 with no estimated release date as of 2026. This primarily affects hospitals and infusion centers that use the IV form for post-transplant patients who cannot take medications orally.

The oral 50 mg tablets — sold as Imuran and under several generic labels — are not on the FDA's formal shortage list. However, the oral supply is unevenly distributed. Multiple generic manufacturers produce azathioprine tablets, but not every pharmacy carries every manufacturer's product, and stocking decisions vary by region, chain, and wholesaler allocation. The result is that one pharmacy may have plenty while the location three miles away has none.

What Causes Imuran Availability Problems?

Several factors combine to create the uneven availability patients experience:

Limited manufacturer base. Only a handful of companies produce generic azathioprine tablets in the United States. A quality control issue, raw material delay, or production shutdown at any one facility can ripple through the entire supply chain.

Broad cross-specialty demand. Azathioprine is prescribed by rheumatologists, gastroenterologists, transplant specialists, neurologists, and dermatologists. This wide cross-indication use means supply must stretch across many patient populations simultaneously.

Injectable shortage spillover. When hospitals cannot obtain IV azathioprine, some facilities crush oral tablets for patients who cannot swallow. This workaround increases demand on the oral supply.

Wholesaler allocation patterns. Large pharmacy chains may receive priority allocations from wholesalers during tight supply periods, leaving independent and small-chain pharmacies with less inventory — or none at all.

Dosage and manufacturer preferences. Some pharmacies stock one manufacturer's 50 mg generic but not another. If your insurance or formulary specifies a particular manufacturer, or if your pharmacy only ordered from one distributor, you may find that specific product out of stock even while others are available nearby.

Why Is Imuran Important to Find Quickly?

Imuran is not a medication where missing doses is a minor inconvenience. For kidney transplant recipients, a gap in immunosuppressive therapy can increase the risk of organ rejection. For patients with rheumatoid arthritis, Crohn's disease, lupus, or myasthenia gravis, skipped doses can trigger disease flares that may require emergency care or hospitalization. Because azathioprine is a slow-acting drug — often taking 6 to 12 weeks to reach full effect — it needs to be taken continuously to maintain its benefit.

What Should You Do If Your Pharmacy Doesn't Have Imuran?

The most important thing is not to panic, but also not to wait. Here are practical steps to take:

Ask about equivalent generics. Azathioprine 50 mg tablets are the same medication regardless of the generic manufacturer. If your pharmacy has a different brand of the generic, ask your doctor and pharmacist about switching.

Call multiple pharmacies. Availability varies significantly by location. Major chains, independent pharmacies, and hospital-affiliated pharmacies often have different stock levels.

Use medfinder.[@portabletext/react] Unknown block type "span", specify a component for it in the `components.types` prop calls pharmacies near you to check which ones can fill your Imuran prescription — saving you the time and frustration of calling around yourself.

Request a 90-day supply. When you do find a pharmacy with stock, ask your doctor for a 90-day prescription to reduce how often you need to refill and re-search.

Talk to your prescriber. If oral Imuran is unavailable for an extended period, your doctor may discuss alternatives such as mycophenolate mofetil (CellCept) or mercaptopurine (Purinethol/6-MP) depending on your underlying condition. Never switch immunosuppressants without medical guidance.

Is There a History of Imuran Shortages?

Yes. Azathioprine tablets experienced a documented shortage between 2014 and 2016 when multiple manufacturers reported problems obtaining active pharmaceutical ingredient (API) and one manufacturer discontinued the product entirely. That shortage was eventually resolved as new suppliers entered the market. The current situation with oral tablets is less severe than the 2014-2016 event, but the injectable shortage has been more persistent — with no resolution date as of early 2026.

The Bottom Line

Finding Imuran in 2026 is manageable but requires more effort than it once did. The oral tablet supply is generally adequate but unevenly distributed — meaning persistence and pharmacy-shopping usually pays off. For a step-by-step guide on locating Imuran near you, see our article on how to find Imuran in stock near you.

If you need help locating Imuran right now, medfinder is a paid service that calls pharmacies near you to find which ones can fill your prescription. You provide your medication and location — medfinder does the calling.